Total planned funding: $463,741,974
Allocations
Countries/Regions
| South Africa | $153,209,967 |
| Kenya | $95,297,673 |
| Nigeria | $64,070,276 |
| Uganda | $29,379,323 |
| Tanzania | $24,840,890 |
| Mozambique | $20,856,959 |
| Ethiopia | $20,842,538 |
| Zimbabwe | $11,560,525 |
| Namibia | $6,609,407 |
| Zambia | $6,507,041 |
| Haiti | $6,082,780 |
| Malawi | $3,764,411 |
| Vietnam | $2,848,095 |
| India | $1,873,887 |
| Lesotho | $1,743,714 |
| Cambodia | $1,723,750 |
| Côte d'Ivoire | $1,319,014 |
| South Sudan | $1,284,565 |
| China | $1,231,005 |
| Democratic Republic of the Congo | $1,134,858 |
| Russia | $1,100,000 |
| Botswana | $1,054,910 |
| Dominican Republic | $823,986 |
| Eswatini | $741,347 |
| Burundi | $720,512 |
| Ghana | $692,067 |
| Caribbean Region | $616,056 |
| Rwanda | $520,161 |
| Ukraine | $425,824 |
| Thailand | $416,191 |
| Indonesia | $275,351 |
| Guyana | $116,626 |
| Cameroon | $41,720 |
| Central Asia Region | $16,545 |
Organizational Types
| Unknown | $463,741,974 |
Program Areas
| Treatment | $463,741,974 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $341,223,373 |
| HTXD: Treatment: ARV Drugs | $72,655,341 |
| PDTX: Treatment: Pediatric Treatment | $49,863,260 |
Top Partner Programs
Not Available:
$441,527,144
View countries